| Clinical characteristics and outcomes in patients with coronavirus disease 2019 and multiple sclerosis C Louapre, N Collongues, B Stankoff, C Giannesini, C Papeix, C Bensa, ... JAMA neurology 77 (9), 1079-1088, 2020 | 453 | 2020 |
| Guillain-Barré syndrome related to SARS-CoV-2 infection K Bigaut, M Mallaret, S Baloglu, B Nemoz, P Morand, F Baicry, A Godon, ... Neurology: Neuroimmunology & Neuroinflammation 7 (5), e785, 2020 | 131 | 2020 |
| DMTs and Covid‐19 severity in MS: a pooled analysis from Italy and France MP Sormani, M Salvetti, P Labauge, I Schiavetti, H Zephir, L Carmisciano, ... Annals of clinical and translational neurology 8 (8), 1738-1744, 2021 | 105 | 2021 |
| Impact of disease-modifying treatments of multiple sclerosis on anti–SARS-CoV-2 antibodies: an observational study K Bigaut, L Kremer, T Fabacher, L Lanotte, MC Fleury, N Collongues, ... Neurology: Neuroimmunology & Neuroinflammation 8 (5), e1055, 2021 | 37 | 2021 |
| Impact of disease-modifying treatments on humoral response after COVID-19 vaccination: a mirror of the response after SARS-CoV-2 infection K Bigaut, L Kremer, M Fleury, L Lanotte, N Collongues, J de Sèze Revue neurologique 177 (10), 1237-1240, 2021 | 34 | 2021 |
| Prognostic indicators and outcomes of hospitalised COVID-19 patients with neurological disease: An individual patient data meta-analysis B Singh, S Lant, S Cividini, JWS Cattrall, LC Goodwin, L Benjamin, ... PLoS One 17 (6), e0263595, 2022 | 33 | 2022 |
| Ocrelizumab for the treatment of multiple sclerosis K Bigaut, J De Seze, N Collongues Expert Review of Neurotherapeutics 19 (2), 97-108, 2019 | 33 | 2019 |
| A rise in cases of nitrous oxide abuse: neurological complications and biological findings M Einsiedler, P Voulleminot, S Demuth, P Kalaaji, T Bogdan, L Gauer, ... Journal of Neurology, 1-6, 2022 | 29 | 2022 |
| An autophagy-targeting peptide to treat chronic inflammatory demyelinating polyneuropathies S Brun, N Schall, SR Bonam, K Bigaut, AG Mensah-Nyagan, J de Sèze, ... Journal of Autoimmunity 92, 114-125, 2018 | 27 | 2018 |
| Severe early-onset impulsive compulsive behavior and psychosis in PLA2G6-related juvenile Parkinson's disease T Wirth, S Weibel, S Montaut, K Bigaut, G Rudolf, J Chelly, C Tranchant, ... Parkinsonism & Related Disorders 41, 127-129, 2017 | 23 | 2017 |
| The translatability of multiple sclerosis animal models for biomarkers discovery and their clinical use D Birmpili, I Charmarke Askar, K Bigaut, D Bagnard International journal of molecular sciences 23 (19), 11532, 2022 | 18 | 2022 |
| Kappa free light chain biomarkers are efficient for the diagnosis of multiple sclerosis: a large multicenter cohort study M Levraut, S Laurent-Chabalier, X Ayrignac, K Bigaut, M Rival, S Squalli, ... Neurology: Neuroimmunology & Neuroinflammation 10 (1), e200049, 2022 | 16 | 2022 |
| Post-vaccine COVID-19 in patients with multiple sclerosis or neuromyelitis optica E Januel, J De Seze, P Vermersch, E Maillart, B Bourre, J Pique, ... Multiple Sclerosis Journal 28 (7), 1155-1159, 2022 | 16 | 2022 |
| How to switch disease-modifying treatments in multiple sclerosis: guidelines from the French Multiple Sclerosis Society (SFSEP) K Bigaut, M Cohen, F Durand-Dubief, E Maillart, E Planque, H Zephir, ... Multiple Sclerosis and Related Disorders 53, 103076, 2021 | 16 | 2021 |
| A multicenter cross-sectional French study of the impact of COVID-19 on neuromuscular diseases LI Pisella, S Fernandes, G Sole, T Stojkovic, C Tard, JB Chanson, ... Orphanet journal of rare diseases 16, 1-9, 2021 | 15 | 2021 |
| Pregnancy and multiple sclerosis: 2022 recommendations from the French multiple sclerosis society S Vukusic, C Carra-Dalliere, J Ciron, E Maillart, L Michel, E Leray, ... Multiple Sclerosis Journal 29 (1), 11-36, 2023 | 14 | 2023 |
| Ocrelizumab versus fingolimod after natalizumab cessation in multiple sclerosis: an observational study K Bigaut, L Kremer, T Fabacher, G Ahle, M Goudot, M Fleury, C Gaultier, ... Journal of Neurology 269 (6), 3295-3300, 2022 | 14 | 2022 |
| Resting-state functional MRI demonstrates brain network reorganization in neuromyelitis optica spectrum disorder (NMOSD) K Bigaut, S Achard, C Hemmert, S Baloglu, L Kremer, N Collongues, ... Plos one 14 (1), e0211465, 2019 | 13 | 2019 |
| Unravelling the etiology of sporadic late-onset cerebellar ataxia in a cohort of 205 patients: a prospective study T Bogdan, T Wirth, A Iosif, A Schalk, S Montaut, C Bonnard, G Carre, ... Journal of Neurology 269 (12), 6354-6365, 2022 | 11 | 2022 |
| BEST-MS: A prospective head-to-head comparative study of natalizumab and fingolimod in active relapsing MS M Cohen, L Mondot, F Bucciarelli, B Pignolet, DA Laplaud, S Wiertlewski, ... Multiple Sclerosis Journal 27 (10), 1556-1563, 2021 | 10 | 2021 |
